James M. Rossetti

James M. Rossetti

Hematology Oncology
5115 Centre Avenue, Hillman Cancer Center
Pittsburgh, PA 15232

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study.

The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study.

Journal: Blood advances
Published: August 19, 2025

The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study.

The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study.

Journal: Blood advances
Published: August 19, 2025

Phase 2 study of the lysine-specific demethylase 1 inhibitor bomedemstat for essential thrombocythemia.

Phase 2 study of the lysine-specific demethylase 1 inhibitor bomedemstat for essential thrombocythemia.

Journal: Blood advances
Published: June 27, 2025

A 40-Year-Old With Prior Stem Cell Transplant for Chronic Myeloid Leukemia Presents With Dyspnea and Respiratory Failure.

A 40-Year-Old With Prior Stem Cell Transplant for Chronic Myeloid Leukemia Presents With Dyspnea and Respiratory Failure.

Journal: Chest
Published: June 21, 2024

A phase II study of post-remission therapy with pembrolizumab in older patients with acute myeloid leukemia.

A phase II study of post-remission therapy with pembrolizumab in older patients with acute myeloid leukemia.

Journal: Haematologica
Published: February 18, 2024

Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy.

Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy.

Journal: Leukemia & lymphoma
Published: February 01, 2023

Institution of Standardized Consultation Criteria to Increase Early Palliative Care Utilization in Older Patients With Acute Leukemia.

Institution of Standardized Consultation Criteria to Increase Early Palliative Care Utilization in Older Patients With Acute Leukemia.

Journal: JCO oncology practice
Published: September 28, 2022

A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML.

A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML.

Journal: Leukemia & lymphoma
Published: September 08, 2022

A prospective study of the use of central venous catheters in patients newly diagnosed with acute myeloid leukemia treated with induction chemotherapy.

A prospective study of the use of central venous catheters in patients newly diagnosed with acute myeloid leukemia treated with induction chemotherapy.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: April 07, 2021

Outcomes of Patients With Acute Myeloid Leukemia Who Relapse After 5 Years of Complete Remission.

Outcomes of Patients With Acute Myeloid Leukemia Who Relapse After 5 Years of Complete Remission.

Journal: Oncology research
Published: August 06, 2020

Acute Myeloid Leukemia Presenting as Effusive Constrictive Pericarditis.

Acute Myeloid Leukemia Presenting as Effusive Constrictive Pericarditis.

Journal: CASE (Philadelphia, Pa.)
Published: April 28, 2020

Outcomes of patients diagnosed with acute myeloid leukemia after solid organ transplantation.

Outcomes of patients diagnosed with acute myeloid leukemia after solid organ transplantation.

Journal: Clinical transplantation
Published: July 03, 2017
Showing 1-12 of 15

Last Updated: 09/26/2026